Alain Meloche

Decisiums is the codification of 25+ years of B2B pricing consulting into a suite of six decision workbenches — bid, procurement, price adjustment, market entry, product enhancement, and decision trees. The methodology is grounded in McFadden discrete-choice modelling and Raiffa decision analysis: decision sciences that Alain studied under Howard Raiffa while earning his MBA at Harvard Business School.

His consulting career spans pharma, medical devices, industrials, software, consumer products, logistics, transportation, and financial services. Documented engagements include the pricing strategy for Roche Diagnostics' PCR commercialization, the two-dimensional volume and technology pricing matrix developed for McKesson's acute care medical-surgical distribution business — part of the technology-stack differentiation McKesson pursued from a third-place market position prior to the business's divestiture to Owens & Minor — and a patent-expiry decision tree analysis at Kemin Industries.

Before moving fully into consulting, Alain held government positions including Executive Assistant to an Associate Deputy Minister and Chief of Shipbuilding. He was later a partner at Harrison Associates, the boutique pricing firm from which Craig Zawada moved to McKinsey and where several of today's Decisiums senior advisors first trained on the methodology the workbenches now operationalize.

Teams default to their most experienced voice, or to spreadsheet scaffolding that cannot be audited, or to intuition dressed as analysis. The six decision workbenches take a different path: an explicit decision structure, an analytical engine that computes defensible recommendations with documented floors and win probabilities, and an AI governance layer that interrogates the recommendations before commitment rather than making the decision itself.

Alain is based in Toronto.